Environmental

R&D intensity at 10.4% of revenue supports product and process innovation, but peers in life-science tools often sustain similar spending, limiting relative advantage.

Negative net debt to EBITDA indicates ample liquidity, which can support environmental compliance and capital upgrades, yet this is not a differentiated ESG signal versus peers.

Gross margin of 58.2% suggests some operating flexibility to absorb energy, waste, and compliance costs, but peer comparison does not indicate clear environmental leadership.

No filing-based evidence provided here shows material emissions, waste, or resource-use disclosures, so environmental positioning appears average rather than structurally advantaged versus peers.

Social

Stock-based compensation equals 1.2% of revenue, implying limited dilution pressure and generally restrained employee incentive cost versus many growth-oriented peers.

R&D spending near 10.4% of revenue can support product quality and customer outcomes, but the metric alone does not demonstrate superior workforce or community practices.

The provided data do not show workforce turnover, safety, diversity, or customer-responsibility disclosures, leaving social positioning difficult to distinguish from peers.

Overall social risk appears manageable, but absent stronger disclosure or third-party evidence, HBIO looks broadly in line with peer norms rather than better.

Governance

Debt-to-equity of 6.0x indicates materially higher leverage than many peers, which can constrain governance flexibility and heighten creditor oversight.

Negative net debt to EBITDA partially offsets balance-sheet concern, but the leverage ratio still suggests a more aggressive capital structure than conservative peers.

Stock-based compensation at 1.2% of revenue is modest, which supports capital discipline relative to peers that rely more heavily on equity incentives.

Without filing evidence on board independence, audit controls, or shareholder rights, governance assessment remains constrained and only moderately positioned versus peers.

Overall Score

HBIO appears broadly in line with peers on ESG, with modestly supportive capital discipline offset by limited disclosure and a comparatively leveraged balance sheet.

Score Driver: Higher Leverage Than Peers Is The Main Factor Limiting Overall ESG Positioning.